Participants
Contact
The “Fundación Madri+d” devotes an article to the study done by Patrick Aloy and Miquel Duran on the side effects of drugs. Published in Chemistry and Biology, the study reveals 1,162 molecular mechanisms that could explain the side effects of about 1000 drugs studied. The bioinformatics analysis undertaken in Aloy’s lab could make a significant contribution to minimizing the list of secondary effects caused by new generation drugs.
Read the report in “Fundación Madri+d" (PDF in Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
